News and Announcements

Dr. Michael Elman welcomes the team from Notal Vision
October 24, 2018

Dr. Michael Elman welcomes the team from Notal Vision on October 24 for the first test in the United States of the next generation in-home patient monitoring. Dr. Elman was a Principal Investigator and served on the Executive Committee of the Home Study. This National Eye Institute clinical trial established the effectiveness of ForeSee Home monitoring in detecting early wet age-related macular degeneration and improved vision over standard care.


Dr. Elman Takes Lead in NIH Study Showing Supplements Prevent Blinding Eye Disease
May 06, 2013

Adding omega-3 fatty acids did not improve a combination of nutritional supplements commonly recommended for treating age-related macular degeneration (AMD), a major cause of vision loss among older Americans, according… Read More


Elman Retina Group provides ForeseeHome services for patients with age-related macular degeneration (AMD)
January 02, 2011

The ForeseeHome™ AMD Monitor is the first ophthalmic device linking patients and doctors between eye exams for ongoing monitoring of age-related macular degeneration (AMD). This telemedicine based system gives doctors… Read More